These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 8751138)

  • 1. Molecular basis of polymorphic drug metabolism.
    Daly AK
    J Mol Med (Berl); 1995 Nov; 73(11):539-53. PubMed ID: 8751138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics of the major polymorphic metabolizing enzymes.
    Daly AK
    Fundam Clin Pharmacol; 2003 Feb; 17(1):27-41. PubMed ID: 12588628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphism of drug metabolizing enzymes: new mutations in CYP2D6 and CYP2A6 genes in Japanese.
    Yokoi T; Kamataki T
    Pharm Res; 1998 Apr; 15(4):517-24. PubMed ID: 9587945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.
    Nebert DW; McKinnon RA; Puga A
    DNA Cell Biol; 1996 Apr; 15(4):273-80. PubMed ID: 8639263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms in drug-metabolizing enzymes and drug targets.
    Hiratsuka M; Mizugaki M
    Mol Genet Metab; 2001 Aug; 73(4):298-305. PubMed ID: 11509011
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update: genetic polymorphism of drug metabolizing enzymes in humans.
    Tanaka E
    J Clin Pharm Ther; 1999 Oct; 24(5):323-9. PubMed ID: 10583694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility.
    Daly AK; Cholerton S; Armstrong M; Idle JR
    Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):55-61. PubMed ID: 7698086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk.
    Brockmöller J; Cascorbi I; Kerb R; Roots I
    Cancer Res; 1996 Sep; 56(17):3915-25. PubMed ID: 8752158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in CYP2E1, GSTM1 and GSTT1 and anti-tuberculosis drug-induced hepatotoxicity.
    Brito TC; Possuelo LG; Valim ARM; Todendi PF; Ribeiro AW; Gregianini TS; Jarczewski CA; Hutz MH; Rossetti MLR; Zaha A
    An Acad Bras Cienc; 2014 Jun; 86(2):855-865. PubMed ID: 30514013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of the cytochromes P450.
    Daly AK
    Curr Top Med Chem; 2004; 4(16):1733-44. PubMed ID: 15579105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High throughput detection of drug-metabolizing enzyme polymorphisms by allele-specific fluorogenic 5' nuclease chain reaction assay.
    Hiratsuka M; Agatsuma Y; Omori F; Narahara K; Inoue T; Kishikawa Y; Mizugaki M
    Biol Pharm Bull; 2000 Oct; 23(10):1131-5. PubMed ID: 11041238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of genetic polymorphisms of drug metabolism.
    Meyer UA; Zanger UM
    Annu Rev Pharmacol Toxicol; 1997; 37():269-96. PubMed ID: 9131254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief review of polymorphic drug-metabolizing enzymes in Japanese populations: development of a higher-throughput genotyping method and proposed applications.
    Kubota T
    Drug Metab Lett; 2007 Apr; 1(2):137-42. PubMed ID: 19356033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on next generation sequencing of pharmacokinetics-related genes: Development of the PKseq panel, a platform for amplicon sequencing of drug-metabolizing enzyme and drug transporter genes.
    Fukunaga K; Momozawa Y; Mushiroda T
    Drug Metab Pharmacokinet; 2021 Apr; 37():100370. PubMed ID: 33508759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of drug-metabolizing enzymes in Italian populations.
    Serpe L; Canaparo R; Scordo MG; Spina E
    Drug Metab Pers Ther; 2015 Jun; 30(2):107-20. PubMed ID: 25527811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphism and toxicology--with emphasis on cytochrome p450.
    Johansson I; Ingelman-Sundberg M
    Toxicol Sci; 2011 Mar; 120(1):1-13. PubMed ID: 21149643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic polymorphisms in xenobiotic metabolizing enzymes as a determinant of susceptibility to environmental mutagens and carcinogens in humans].
    Ozawa S
    Yakugaku Zasshi; 1997 Nov; 117(10-11):895-909. PubMed ID: 9414599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.
    Sachse C; Smith G; Wilkie MJ; Barrett JH; Waxman R; Sullivan F; Forman D; Bishop DT; Wolf CR;
    Carcinogenesis; 2002 Nov; 23(11):1839-49. PubMed ID: 12419832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of drug metabolizing enzymes in the effect and side-effect of the drugs].
    Vereczkey L; Jemnitz K; Monostory K; Veres Z; Kóbori L
    Orv Hetil; 2005 May; 146(19):947-52. PubMed ID: 15969306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.